For CVS Health Corp. provide the crucial ratios in all five categories. Prepare a table showing the ratios calculated from the latest fiscal year -- and compare to the previous year

• Liquidity Ratios.
• 
  
• Activity Ratios.
• 
  
• Debt Ratios.
• 
  
• Profitability Ratios.
• 
  
• Market Ratios

 

Transcribed Image Text:

Consolidated Statements of Cash Flows For the Years Ended December 31, 2019 In millions 2018 2017 Cash flows from operating activities: Cash receipts from customers $ 248,393 S 186,519 $ 176,594 Cash paid for inventory and prescriptions dispensed by retail network pharmacies (148,981) (146,469) (149,655) Insurance benefits paid (52,242) (6,897) (2,810) Cash paid to other suppliers and employees (28,932) (17,234) (15,348) Interest and investment income received 955 644 21 Interest paid (2,954) (2,803) (1,072) Income taxes paid (2,717) (2,383) (2,909) Net cash provided by operating activities 12,848 8,865 8,007 Cash flows from investing activities: Proceeds from sales and maturities of investments 7,049 817 61 Purchases of investments (7,534) (692) (137) Purchases of property and equipment (2,457) (2,037) (1,918) Proceeds from sale-leaseback transactions 265 Acquisitions (net of cash acquired) (444) (42,226) (1,181) Proceeds from sale of subsidiary and other assets 832 Other 42 21 33 Net cash used in investing activities (3,339) (43,285) (2,877) Cash flows from financing activities: Net repayments of short-term debt (720) (556) (598) Proceeds from issuance of long-term debt 3,736 44,343 Repayments of long-term debt (8,336) (5,522) Derivative settlements (25) 446 Repurchase of common stock (4,361) Dividends paid (2,603) (2,038) (2,049) Proceeds from exercise of stock options 210 242 329 Payments for taxes related to net share settlement of equity awards (112) (97) (71) Other 1 (1) Net cash provided by (used in) financing activities (7,850) 36,819 (6,751) Effect of exchange rate changes on cash, cash equivalents and restricted cash (4) 1 Net increase (decrease) in cash, cash equivalents and restricted cash 1,659 2,395 (1,620) Cash, cash equivalents and restricted cash at the beginning of the period 4,295 1,900 3,520 Cash, cash equivalents and restricted cash at the end of the period 5,954 S 4,295 $ 1,900 Consolidated Statements of Cash Flows For the Years Ended December 31, 2019 In millions 2018 2017 Cash flows from operating activities: Cash receipts from customers $ 248,393 S 186,519 $ 176,594 Cash paid for inventory and prescriptions dispensed by retail network pharmacies (148,981) (146,469) (149,655) Insurance benefits paid (52,242) (6,897) (2,810) Cash paid to other suppliers and employees (28,932) (17,234) (15,348) Interest and investment income received 955 644 21 Interest paid (2,954) (2,803) (1,072) Income taxes paid (2,717) (2,383) (2,909) Net cash provided by operating activities 12,848 8,865 8,007 Cash flows from investing activities: Proceeds from sales and maturities of investments 7,049 817 61 Purchases of investments (7,534) (692) (137) Purchases of property and equipment (2,457) (2,037) (1,918) Proceeds from sale-leaseback transactions 265 Acquisitions (net of cash acquired) (444) (42,226) (1,181) Proceeds from sale of subsidiary and other assets 832 Other 42 21 33 Net cash used in investing activities (3,339) (43,285) (2,877) Cash flows from financing activities: Net repayments of short-term debt (720) (556) (598) Proceeds from issuance of long-term debt 3,736 44,343 Repayments of long-term debt (8,336) (5,522) Derivative settlements (25) 446 Repurchase of common stock (4,361) Dividends paid (2,603) (2,038) (2,049) Proceeds from exercise of stock options 210 242 329 Payments for taxes related to net share settlement of equity awards (112) (97) (71) Other 1 (1) Net cash provided by (used in) financing activities (7,850) 36,819 (6,751) Effect of exchange rate changes on cash, cash equivalents and restricted cash (4) 1 Net increase (decrease) in cash, cash equivalents and restricted cash 1,659 2,395 (1,620) Cash, cash equivalents and restricted cash at the beginning of the period 4,295 1,900 3,520 Cash, cash equivalents and restricted cash at the end of the period 5,954 S 4,295 $ 1,900

Answer rating: 100% (QA)

Given Data 2019 2018 Current Asset 5030200 4524300 Inventories 1751600 1645000 Cash and cash equival... View the full answer